Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Tschernutter Marion |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Weber, P; Pabst, B; Paschke, E; Schalli, M; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG; Wrodnigg, TM
Cyclopentanoid D-Galactosidase Inhibitors and potential Pharmacological Chaperones for GM1-Gangliosidosis
29th International Carbohydrate Symposium; Jul 14-19, 2017; Lisbon, PORTUGAL. 2018.
[Poster]
Weber, P; Pabst, B; Paschke, E; Schalli, M; Stütz, AE; Tschernutter, M; Windischhofer, W; Wolfsgruber, A; Wrodnigg, TM
CYCLOPENTANOID N-ACETYL-β-D-HEXOSAMINIDASE INHIBITORS.
29th International Carbohydrate Symposium; Jul 14-19, 2018; Lisbon, PORTUGAL. 2018.
[Poster]
Wolfsgruber, A; Nasseri, SA; Pabst, B; Paschke, E; Schalli, M; Stütz, AE; Torvisco Gomez, A; Müller, P; Tschernutter, M; Weber, P; Windischhofer, W; Withers, SG; Wrodnigg, TM
FURANOID CARBASUGARS AS GH 20 HEXOSAMINIDASE INHIBITORS AND POTENTIAL PHARMACOLOGICAL CHAPERONES.
29th International Carbohydrate Symposium; Jul 14-19, 2018; Lisbon, PORTUGAL. 2018.
[Poster]
Lebl, R; Schalli, M; Tysoe, C; Pabst, B; Paschke, E; Stütz, AE; Tschernutter, M; Weber, P; Windischhofer, W; Withers, SG; Wrodnigg, TM; Zoidl, M
A Morita-Baylis-Hillman Based de novo Synthesis of 5a-C-Pentyl-4-epi-Isofagomine - A Powerful Pharmacological Chaperone for GM1-Gangliosidosis.
21st Austrian Carbohydrate Workshop; Feb 16-17, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Lebl, R; Thonhofer, M; Tysoe, C; Pabst, B; Paschke, E; Schalli, M; Stütz, AE; Tschernutter, M; Weber, P; Windischhofer, W; Withers, SG; Wrodnigg, TM; Zoidl, M
Synthesis of 5a-C-Extended 4-epi-Isofagomine Derivatives from D-Glyceraldehyde – Powerful Pharmacological Chaperones for GM1-Gangliosidosis.
19th European Carbohydrate Symposium; Jul 3-6, 2017; Barcelona, SPAIN. 2017.
[Poster]
Schalli, M; Thonhofer, M; Lebl, R; Weber, P; Tysoe, C; Pabst, B; Paschke, E; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG; Wrodnigg, TM; Zoidl, M
Experimental Pharmacological Chaperones for Lysosomal Glycosidase Mutants.
19th European Carbohydrate Symposium; Jul 3-6, 2017; Barcelona, SPAIN. 2017.
[Poster]
Schalli, M; Weber, P; Tysoe, C; Pabst, B; Lebl, R; Paschke, E; Stütz, AE; Tschernutter, M; Windischhofer, W; Withers, SG; Wrodnigg, TM; Zoidl, M
N-Substituted 5-amino-1-hydroxymethyl-Cyclopentanetriols: A new Family of Promotors for GM1-Gangliosidosis Related Human Lysosomal β-Galactosidase Mutants.
19th European Carbohydrate Symposium; Jul 3-6, 2017; Barcelona, SPAIN. 2017.
[Poster]
Tschernutter, M
Etablierung eines Zellmodells für vererbbare lysosomale Speichererkrankungen
MPS-Sommertagung
; JUL 13-15, 2017; Maria Alm, AUSTRIA. 2017.
[Oral Communication]
Weber, P; Lebl, R; Müller, S; Pabst, B; Paschke, E; Schalli, M; Stütz, AE; Tschernutter, M; Tysoe, C; Windischhofer, W; Withers, SG; Wrodnigg, TM; Zoidl, M
Furanoid Carbasugars as Hexosaminidase Inhibitors and Potential Pharmacological Chaperones.
19th European Carbohydrate Symposium; Jul 3-6, 2017; Barcelona, SPAIN. 2017.
[Poster]
Thonhofer, M; Fischer, R; Gonzales-Santana, A; Hojnik, C; Lebl, R; Papst, B; Schalli, M; Stütz, AE; Tschernutter, M; Weber, P; Windischhofer, W; Withers, SG; Wrodnigg, TM; Zoidl, M
Synthesis and biological evaluation of C-5a extended derivatives of 4-epi-isofagomine.
20th Austrian Carbohydrate Workshop; Feb 11-12, 2015; Wien. 2016.
[Oral Communication]
Tschernutter, M
Modeling inherited neurological disorders
Cell Culture Days 2016; Apr 28-29, 2016; Graz, Austria. 2016.
[Oral Communication]
FullText
Tschernutter, M
Long-term follow up of a MPS 1H patient after allogenic non-myeloablative stem cell therapy.
14th International Postgraduate Course on Lysosomal Storage Disorders; MAY 31- JUNE 4, 2015; Nierstein, GERMANY. 2015.
[Oral Communication]
Tschernutter, M; Kaiser, T; Fauler, G; Pabst, B; Windischhofer, W; Paschke, E
Towards a Metabolomic Assay of Monosialoganglioside Turnover in Normal and GM1 Gangliosidosis Fibroblasts with High Resolution Q-Exactive Orbitrap LC/MS
ESGLD; SEP 30- OKT 4, 2015; Pozzuoli (Naples). 2015.
[Poster]
Chromikova, V; Steinfellner, W; Tschernutter, M; Kunert, R
Developing monoclonal IgM-producing CHO cell lines for the purpose of further investigation of the product.
ÖGMBT; SEP 28-30 2011; Puch, Austria. 2011.
[Poster]
Bennett, KL;Funk, M; Pollreisz, A; Tschernutter, M; Planyavsky, M; Parapatics, K; Breitwieser, FP; Mohien, CU; Mueller, A; Trajanoski, Z; Colinge, J; Superti-Furga, G; Schmidt-Erfurth, U
‘Eye-Tracking’ of Proteins from Human Intraocular Fluids – Qualitative and Quantitative Approaches Toward Understanding the Progression of Eye Disease.
ASMS; May 23 – 27, 2010; Utah, USA. 2010.
[Poster]
Reinhart, D; Tschernutter, M; Kunert, R
The next generation of 3D6 and 4B3: Isotype switch of two NNAbs to dIgA and sIgA
EuroNeut-41 Discovery Meeting; MAY 3-4, 2010; Paris, FRANCE . 2010.
[Poster]
Reinhart, D; Tschernutter, M; Kunert, R.
Recombinant expression of anti-gp41 antibodies as dimeric and secretory IgA
Europrise Annual Conference; NOV 15-18, 2010; Lisbon, PORTUGAL . 2010.
[Poster]
Georgiadis, A; Tschernutter, M; Bainbridge, JWB; Robbie, SJ; Smith, AJ; Ali, RR.
AAV-mediated shRNA and miRNA Silencing of Murine Peripherin-2 in vivo.
ARVO; APR, 2009; Florida, USA. 2009.
[Poster]
FullText
Georgiadis, A; Tschernutter, M; Bainbridge, JWB; Balaggan, KS; Mowat, F; Balda, MS; Matter, K; Ali, RR
Lentivirus-mediated RNA interference disrupts junctional signalling in the RPE.
ARVO; MAY, 2008; Florida, USA. 2008.
[Poster]
FullText
Ballagan, KS; Duran, Y; Buch, PK; MacNeil, A; Tschernutter, M; Bainbridge, JWB; Smith, AJ; Ali, RR
Specific Evaluation of the Oncogenic Potential of AAV2/2 Vectors after Intraocular Delivery in p53 Knockout Mice.
ARVO; MAY, 2007; Florida, USA. 2007.
[Poster]
FullText
MacLaren, RE; Buch, PK; Georgiadis, A; Tschernutter, M; Pearson, RA; Smith, AJ; Ali, RR
Assessment of Lifetime Neuroprotection by CNTF Gene Transfer in an Inherited Retinal Degeneration.
ARVO; MAY, 2007; Florida, USA. 2007.
[Poster]
FullText
Balda, MS; Georgiadis, A;Tschernutter, M; Balagan, K; Ali, RR; Vugler, A; Greenwood, J; Matter, K
ZONAB and ZO-1 Are Involved in the Differentiation of Retinal Pigment Epithelium.
ARVO; MAY, 2005; Florida, USA. 2005.
[Poster]
FullText
Tschernutter, M; Waseem, NH; Perkins, A; Bhattacharya, SS; Holder, GE; Jenkins, SA; Bird, AC; Ali, RR; Webster, AR
Detailed Clinical Characteristics of a Family Segregating a Novel Mutation in the Mertk Gene.
ARVO; MAY, 2005; Florida, USA. 2005.
[Poster]
FullText
Schlichtenbrede, FC; Tschernutter, M; Bainbridge, JWB; Buch, P; Georgiadis, A; Smith, AJ; Ali, RR
Gene therapy leads to long term improvement of retinal function in the heterozygous retinal degeneration slow mouse (rds+/-).
ARVO; MAY, 2004; Florida, USA. 2004.
[Poster]
FullText
Balaggan, KS; Bainbridge, JWB; Tschernutter, M; Esapa, M; Binley, K; Naylor, S; Ali, RR
Evaluation of Minimal EIAV Based Vectors for Intraocular Gene Tranfer.
ARVO; MAY, 2003; Florida, USA. 2003.
[Poster]
FullText
Schlichtenbrede, FC; Smith, AJ; Tschernutter, M; Thrasher, AJ; Bainbridge, JWB; Ali, RR
Long Term Preservation of Retinal Function in the RCS Rat Model of Retinitis Pigmentosa following Lentivirus-mediated Gene Transfer of the Mertk Gene
ARVO; MAY, 2003; Florida, USA. 2003.
[Poster]
FullText
Tschernutter, M; Schlichtenbrede, FC; Howe, S; Bainbridge, JWB; Thrasher, AJ; Smith, AJ; Ali, RR
Long term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene replacement therapy.
ESGT; NOV 14-17, 2003; Edinburgh, SCOTLAND. 2003.
[Poster]